[Elsevier] Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia |
|
This post will be closed automatically in 2026-08-31 04:17
Reward10points
|
10
Artificial intelligence and corporate ESG: Evidence from Chinese listed enterprises
10
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
10
Artificial intelligence and corporate ESG performance
10
Direct manufacturing of diamond composite coatings onto silicon wafers and heat transfer performance
10
[Supplementary]A dual-color whole-cell biosensor for differential visual detection of As(III) and Hg(II) at drinking water limits
